By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1 North Waukegan Road

North Chicago  Illinois  60064  U.S.A.
Phone: 1-800-255-5162 Fax: n/a


AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries.

Key Statistics

Ownership: Public

Web Site: AbbVie
Symbol: ABBV


Company News
AbbVie (ABBV) To Present At The Goldman, Sachs & Co. 37th Annual Global Healthcare Conference 5/31/2016 8:20:05 AM
AbbVie (ABBV) Release: European Commission (EC) Approves IMBRUVICA (Ibrutinib) For First-Line Treatment Of Patients With Chronic Lymphocytic Leukemia 5/31/2016 6:24:02 AM
FDA Approves Biogen (BIIB) and AbbVie (ABBV)'s Once-Monthly MS Drug Zinbryta 5/31/2016 6:10:48 AM
AbbVie (ABBV)'s HUMIRA (Adalimumab) Receives CHMP Positive Opinion To Treat Certain Forms Of Non-Infectious Uveitis, A Disease That Can Severely Impact Vision[1] 5/27/2016 6:33:37 AM
AbbVie (ABBV) To Present At The Jefferies 2016 Healthcare Conference 5/26/2016 7:36:12 AM
Innovus Pharma Joins AbbVie (ABBV) And Eli Lilly (LLY) In The Race For The $3 Billion Testosterone Replacement Market 5/24/2016 11:23:32 AM
AbbVie (ABBV) Release: IL-23 Inhibitor Risankizumab Induces Remission In Phase II Study In Patients With Moderate-To-Severe Crohn's Disease 5/24/2016 10:15:45 AM
AbbVie (ABBV)'s Leadership In Gastroenterology Showcased At Digestive Disease Week With New HUMIRA (Adalimumab) Long-Term, Real-World Research And Promising Anti-IL-23 Antibody Late-Breaking Data 5/19/2016 9:27:07 AM
AbbVie (ABBV) Demonstrates Progress In Oncology Research At ASCO 2016 Annual Meeting With Multiple Abstracts Evaluating Eight Medicines Across Cancer Types 5/19/2016 7:05:19 AM
AbbVie (ABBV) and Biogen (BIIB) Have Ribbon-Cutting Ceremonies for Two New Sites in Massachusetts, Bring on 250+ New Jobs 5/18/2016 6:50:01 AM